Back to Journals » Journal of Blood Medicine » Volume 12

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)

Total article views   HTML views PDF downloads Totals
6,731 Dovepress* 6,355+ 520 6,875
PubMed Central* 376 111 487
Totals 6,731 631 7,362
*Since 21 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar